Chain-of-thought monitorability could improve generative AI safety by assessing how models come to their conclusions and ...

Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

On the early evening of June 22, 2010, American tennis star John Isner began a grueling Wimbledon match against Frenchman ...

Late last year, Dominic King and Christopher Kelly were poached by Suleyman from DeepMind to run a new AI health unit that ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

After years of development, Murdoch says human clinical trials for Isomorphic’s AI-designed drugs are finally within reach.

Google’s DeepMind and OpenAI, which makes ChatGPT, say they both achieved a gold medal-level performance at this year's ...

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...

Among new hires, former Google Gemini engineering lead Amar Subramanya joined Microsoft AI as corporate vice-president.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling breakthroughs.